•21 May 2023 09:29
China Healthcare Weekly (May.19) - "Hedge Logic" Of CXO, Beijing's DRG+VBP Policy, Zylox-Tonbridge
Beijing issued new VBP+DRG policy for sports medicine/neurointervention/electrophysiology. CXO's "hedge logic" doesn't guarantee the whole industry...
•15 May 2023 08:55
Acotec Scientific (6669.HK) - What Value Boston Scientific Will Bring Is Crucial to Future Valuation
There're many highlights in Acotec’s performance last year,but growth ceiling is obvious if rely solely on China market.Boston Scientific's...
•26 Jan 2023 22:50
Acotec (6669 HK): Boston Scientific’s HK$20 Partial Offer Unconditional
Based on the current proration of 82.71% and at the last close price of HK$19.78 per share, the breakeven price is HK$19.00 per share.
•03 Jan 2023 16:47
Acotec (6669 HK): Boston Scientific’s HK$20 Partial Offer Now Open
Irrevocables ensure that it will be declared unconditional on or before the first closing date. Based on a minimum proration of 71.31% and at the...
•11 Dec 2022 09:10